Skip to content

Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.

Randomized controlled trial · Ophthalmology · 1989. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 2780003

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.

Camras CB, Siebold EC, Lustgarten JS et al.
Ophthalmology · 1989

PubMed ID
2780003
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.